Phase Ii Study of Cetuximab Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for the First-Line Treatment of Advanced Gastric Cancer

腫瘤醫學研究所YEH, KUN-HUEIKUN-HUEIYEHHSU, CHIH-HUNGCHIH-HUNGHSUHSU, CHIUNCHIUNHSULIN, CHING-HUNGCHING-HUNGLINSHEN, YING-CHUNYING-CHUNSHENCHIOU, TZEON-JYETZEON-JYECHIOUCHAO, YEEYEECHAOCHENG, ANN-LIIANN-LIICHENG2011-06-242018-07-092011-06-242018-07-092009http://ntur.lib.ntu.edu.tw//handle/246246/235715en-US[SDGs]SDG3Phase Ii Study of Cetuximab Plus Weekly Cisplatin and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin for the First-Line Treatment of Advanced Gastric Cancer